期刊文献+

血清同型半胱氨酸与胱蛋白酶抑制剂C在老年高血压患者中的检测意义 被引量:2

Detection significance of serum homocysteine and cystatin C in senile hypertension patients
下载PDF
导出
摘要 目的分析老年高血压患者血清同型半胱氨酸(Hcy)与胱蛋白酶抑制剂C(Cyst C)检测水平的临床意义。方法 70例老年高血压患者作为观察组,75例健康体检者作为对照组,比较两组研究对象的Hcy、Cyst C表达水平。结果观察组Hcy、Cyst C水平均高于对照组,差异具有统计学意义(P<0.05)。结论 Hcy、Cyst C水平可作为诊断老年高血压的标准之一,且高Cyst C水平可作为早期肾损害的指标之一。 Objective To analyze clinical significance of serum homocysteine(Hcy) and cystatin C(Cyst C) detection for senile hypertension patients. Methods There were 70 senile hypertension patients as observation group, and 75 healthy people as control group. Their Hcy and Cyst C levels were compared. Results The observation group had higher Hcy and Cyst C levels than the control group, and their differences had statistical significance(P〈0.05). Conclusion Hcy and Cyst C levels can be used as one of the diagnosis standards for senile hypertension. Moreover, high Hcy and Cyst C levels is one of the indexes for early renal damage.
作者 杨芳
出处 《中国实用医药》 2015年第22期17-18,共2页 China Practical Medicine
关键词 老年高血压 同型半胱氨酸 胱蛋白酶抑制剂C 临床意义 Senile Hypertension Homocysteine Cystatin C Clinical significance
  • 相关文献

参考文献7

二级参考文献50

  • 1陈雅丽,李凌,赵晓燕,王丽蕊,董文杰,肖莉丽,朱慎慎.高血压患者腔隙性脑梗死的发生与血浆同型半胱氨酸及胰岛素水平的关系[J].中国实用医刊,2010,37(4):62-63. 被引量:2
  • 2毕增祺,徐红,主理群.对几种测定老年人肾小球滤过率方法的评估[J].中华老年医学杂志,2006,25(1):25-28. 被引量:18
  • 3Fesler P, Ribstein J, du Cailar G, et al. Determinants of cardiorenal damage progression in normotensive and never treated hypertensive subjects [J].Kidney Int, 2005, 67 (5): 1974 -1979.
  • 4Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate [J]. Clin Chem, 2002, 48 (5): 699-707.
  • 5Mussap M, Plebani M. Biochemistry and clinical role of human cystatin C[J].Crit Rev Clin Lab Sci, 2004, 41 (5- 6):467- 550.
  • 6Tanaka A, Suemaru K, Otsuka T, et al. Estimation of the initial dose setting of vaneomycin therapy using eystatin C as a new marker of renal function [J]. Ther Drug Monit, 2007, 29 (2) : 261-264.
  • 7Loew M, Hoffmann MM, Koenig W, et al. Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events [J]. Arterio- scler Thromb Vasc Biol, 2005, 25 (7): 1470-1474.
  • 8Watanabe S, Okura T, Liu J, et al. Serum eystatin C level is a marker of end organ damage in patients with essential hypertension [J]. Hypertens Res, 2003, 26 (1): 895-899.
  • 9Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons[J]. N Engl J Med, 2005, 352 (20): 2049-2060.
  • 10Hoang K,Tan JC,Derby G,et al.Determinants of glomer-ular hypofiltration in aging humans[J].Kidney Int,2003,64(4):1417-1724.

共引文献88

同被引文献25

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部